ArticleAmerican journal of respiratory and critical care medicine2024
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.
Registry-linked trialAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07328035 (Remission in Adults With Severe Asthma in Thailand), which is not on this map. Cited by 78 papers.
0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Remission in Adults With Severe Asthma in Thailand
Who cites it
78 citing papers in PubMed.
- Evaluating Asthma Clinical Remission with Inhaled Therapy: Post Hoc Analyses of CAPTAIN.Advances in therapy · 2026Trial
- Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies.The European respiratory journal · 2024Trial
- Small airway dysfunction as a functional barrier to spirometry-defined clinical remission in severe asthma treated with biologic therapies.The World Allergy Organization journal · 2026Article
- Impact of Chronic Stress and Trauma on Asthma Pathophysiology and Outcomes.Current allergy and asthma reports · 2026Review
- Biologic effectiveness increases with earlier biologic initiation after severe asthma onset.The journal of allergy and clinical immunology. Global · 2026Article
- Incidence of New Malignancies in Severe Asthma: Comparison of Real-World Patients Treated with Benralizumab, Other Biologics, or Non-biologics.Pulmonary therapy · 2026Article
- Review
- Review
- From mild-to-moderate to severe asthma: risk factors and patient profiles from the NORDSTAR cohort.American journal of respiratory and critical care medicine · 2026Observational
- Asthma remission following inhaled treatments.ERJ open research · 2026Article
- Longer Asthma Duration Is Associated With Elevated Non-T2 Sputum Biomarkers and Reduced T2 Inflammation in Severe Asthma.Allergy · 2026Observational
- Clinical Remission is Achievable for Adult Patients with Severe Asthma Receiving Mepolizumab: A European Retrospective Chart Review.Advances in therapy · 2026Article
- Real-World Effectiveness of Dupilumab in Severe Uncontrolled Asthma: Clinical Remission on Treatment, Predictors of Complete Response and Impact on Type-2 Comorbidities.Journal of clinical medicine · 2026Article
- Mechanisms and therapeutic strategies of asthma: from bench to bedside.Signal transduction and targeted therapy · 2026Review
- High degree of remission in pediatric severe asthma patients treated with biologics in a real-world setting.The World Allergy Organization journal · 2026Article
- Delphi Consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP) on the management of severe asthma in children and adolescents.Multidisciplinary respiratory medicine · 2026Article
- COMSA-MEWS: a simple quantitative algorithm for determining response to biologics in severe asthma, tested in a real-world mepolizumab study.ERJ open research · 2026Article
- Self-directed de-escalation of maintenance inhaler therapy in patients with severe asthma in remission with biologic treatment: An observational study.The journal of allergy and clinical immunology. Global · 2026Article
- Real-world characterisation of severe asthma in Greece: results from the Greek Severe Asthma Registry.ERJ open research · 2026Article
- Improvements in small airway dysfunction and respiratory symptoms following tezepelumab for severe asthma.ERJ open research · 2026Article
18 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
55 authors.
Luis Perez-de-LlanoPneumology Service, Lucus Augusti University Hospital, EOXI Lugo, Monforte, Cervo, Spain.ORCID 0000-0003-2652-6847
Ghislaine SceloObservational and Pragmatic Research Institute, Singapore, Singapore.ORCID 0000-0002-2692-8507
Trung N TranBioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland.ORCID 0000-0001-8003-7601
Tham T LeBioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland.ORCID 0000-0003-3648-5858
Malin FageråsBioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.
Borja G CosioSon Espases University Hospital, IdISBa, Ciberes, Mallorca, Spain.ORCID 0000-0002-6388-8209
Matthew PetersDepartment of Thoracic Medicine, Concord Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-9649-8741
Paul E PfefferDepartment of Respiratory Medicine, Barts Health National Hospital Service Trust.ORCID 0000-0003-0369-2885
Mona Al-AhmadMicrobiology Department, College of Medicine, Kuwait University, Al-Rashed Allergy Center, Ministry of Health, Kuwait.ORCID 0000-0003-2950-5363
Riyad O Al-LehebiDepartment of Pulmonology, King Fahad Medical City, and.ORCID 0000-0002-3232-6668
Alan AltrajaDepartment of Pulmonology, University of Tartu and Lung Clinic, Tartu University Hospital, Tartu, Estonia.ORCID 0000-0001-7798-9871
Celine BergeronCentre for Lung Health, Vancouver General Hospital.ORCID 0000-0003-2585-5411
Leif H BjermerRespiratory Medicine and Allergology, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.ORCID 0000-0002-3441-8099
Anne S BjerrumDepartment of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.ORCID 0009-0002-1657-2399
Lakmini BulathsinhalaObservational and Pragmatic Research Institute, Singapore, Singapore.ORCID 0009-0007-0466-4671
John BusbyCentre for Public Health, School of Medicine, Dentistry, and Biomedical Sciences, and.ORCID 0000-0003-4831-7464
Diana J Cano RosalesInstituto Neumológico del Oriente, Bucaramanga, Santander, Colombia.ORCID 0000-0002-7090-5142
Giorgio W CanonicaPersonalized Medicine, Asthma, and Allergy, IRCCS Humanitas Research Hospital, Rozzano, Italy.ORCID 0000-0001-8467-2557
Victoria A CarterObservational and Pragmatic Research Institute, Singapore, Singapore.ORCID 0000-0002-0333-3308
Jeremy CharriotPhyMedExp, University Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France.ORCID 0000-0002-1420-5774
George C ChristoffMedical University, Sofia, Bulgaria.ORCID 0000-0003-4549-7711
Eve J DentonAllergy, Asthma, and Clinical Immunology Service, Alfred Health, Melbourne,Victoria, Australia.ORCID 0000-0003-1482-7626
Delbert R DorscheidCenter for Heart Lung Innovation, and.ORCID 0000-0002-0680-0258
Maria J Fernandez SanchezPulmonary Unit, Hospital Universitario San Ignacio, Bogota, Colombia.ORCID 0000-0001-6461-2725
João A FonsecaCINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal.
Peter G GibsonAustralian Severe Asthma Network, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, New South Wales, Australia.
Celine Y Y GohObservational and Pragmatic Research Institute, Singapore, Singapore.
Liam G HeaneyWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.
Enrico HefflerPersonalized Medicine, Asthma, and Allergy, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Mark HewAllergy, Asthma, and Clinical Immunology Service, Alfred Health, Melbourne,Victoria, Australia.
Takashi IwanagaKindai University Hospital, Osakasayama, Japan.ORCID 0000-0001-9155-265X
Rohit KatialDivision of Allergy and Clinical Immunology and.ORCID 0000-0002-0627-2467
Mariko S KohDepartment of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.ORCID 0000-0002-1230-0129
Piotr KunaDivision of Internal Medicine, Asthma, and Allergy, Medical University of Lodz, Lodz, Poland.ORCID 0000-0003-2401-0070
Désirée E S Larenas-LinnemannCentro de Excelencia en Asma y Alergia, Hospital Médica Sur, Ciudad de México, México.ORCID 0000-0002-5713-5331
Lauri LehtimäkiAllergy Centre, and.ORCID 0000-0003-1586-4998
Bassam MahboubRashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates.ORCID 0000-0002-6089-438X
Neil MartinBioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.ORCID 0000-0003-3115-3328
Hisako MatsumotoDepartment of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine, Osaka, Japan.
Andrew N Menzies-GowBioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.
Nikolaos G PapadopoulosDivision of Infection, Immunity, and Respiratory Medicine, University of Manchester, Manchester, United Kingdom.
Todor A PopovUniversity Hospital Sv. Ivan Rilski, Sofia, Bulgaria.
Celeste M PorsbjergResearch Unit, Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark.
Pujan PatelRespiratory Medicine, Royal Brompton Hospital, London, United Kingdom.
Chin K RheeDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.ORCID 0000-0003-4533-7937
Mohsen SadatsafaviRespiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Camille TailléRespiratory Diseases Department, Hôpital Bichat, AP-HP Nord-Université Paris Cité, Paris, France.
Carlos A Torres-DuqueCINEUMO, Respiratory Research Center, Fundación Neumológica Colombiana, Bogotá, Colombia.ORCID 0000-0003-0004-8955
Ming-Ju TsaiDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, and.
Charlotte S UlrikDepartment of Respiratory Medicine, Copenhagen University Hospital, Hvidovre, Denmark.ORCID 0000-0001-8689-3695
John W UphamFaculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-0017-3433
Anna von BülowResearch Unit, Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark.ORCID 0009-0005-3268-785X
Eileen WangDivision of Allergy and Clinical Immunology, Department of Medicine, National Jewish Health, Denver, Colorado.ORCID 0000-0002-3149-3229
Michael E WechslerNJH Cohen Family Asthma Institute, Department of Medicine, National Jewish Health, Denver, Colorado.ORCID 0000-0003-3505-2946
David B PriceObservational and Pragmatic Research Institute, Singapore, Singapore.ORCID 0000-0002-9728-9992
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AsthmaRemission InductionAdultAgedAnti-Asthmatic AgentsBiological ProductsCohort StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedRegistriesSeverity of Illness IndexTreatment OutcomeAnti-Asthmatic AgentsBiological Productsanti-IgEanti-IL4Rαanti-IL5/5Rexacerbationlung function
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
NCT07328035ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.